Q192R Polymorphism of Paraoxonase 1 Gene Associated with Insulin Resistance in Mexican Children

Mackness, 1993, Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase, Atherosclerosis, 104, 129, 10.1016/0021-9150(93)90183-U Whaley-Connell, 2011, The role of oxidative stress in the metabolic syndrome, Rev Cardiovasc Med, 12, 21, 10.3909/ricm0555 Heinecke, 1998, Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?, Am J Hum Genet, 62, 20, 10.1086/301691 Juretić, 2006, Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus, Acta Pharm, 56, 59 La Du, 1993, Studies on human serum paraoxonase/arylesterase, Chem Biol Interact, 87, 25, 10.1016/0009-2797(93)90022-Q Ferré, 2013, Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome, Clin Biochem, 46, 1830, 10.1016/j.clinbiochem.2013.08.020 Krzystek-Korpacka, 2013, Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress, Adv Clin Exp Med, 2, 229 Koren-Gluzer, 2011, The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release, Atherosclerosis, 219, 510, 10.1016/j.atherosclerosis.2011.07.119 Koren-Gluzer, 2013, Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway, Atherosclerosis, 229, 71, 10.1016/j.atherosclerosis.2013.03.028 Rudich, 1998, Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes, Diabetes, 47, 1562, 10.2337/diabetes.47.10.1562 Vávrová, 2013, Altered activities of antioxidant enzymes in patients with metabolic syndrome, Obes Facts, 6, 39, 10.1159/000348569 Brophy, 2001, Effects of 5V regulatory-region polymorphisms on paraoxonase-gene (PON1) expression, Am J Hum Genet, 68, 1428, 10.1086/320600 Mackness, 1998, Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification, FEBS Lett, 423, 57, 10.1016/S0014-5793(98)00064-7 Pérez-Herrera, 2008, PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy, Exp Mol Pathol, 85, 129, 10.1016/j.yexmp.2008.05.003 Veiga, 2011, Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women, Eur J Endocrinol, 164, 213, 10.1530/EJE-10-0825 National Cholesterol Education Program (NCEP) Expert Panel on Detection, 2002, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Al-Hakeem, 2014, Relationship between the paraoxonase 1 gene glutamine 192 to arginine polymorphism and gestational diabetes mellitus in Saudi women, Clin Biochem, 47, 122, 10.1016/j.clinbiochem.2014.07.005 Pfohl, 1999, Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes, Diabetes, 48, 623, 10.2337/diabetes.48.3.623 Koch, 2001, Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes, Exp Clin Endocrinol Diabetes, 109, 141, 10.1055/s-2001-14836 Gupta, 2011, Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population, Gene, 487, 88, 10.1016/j.gene.2011.07.011 Hassan, 2013, The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects, Mol Cell Biochem, 380, 121, 10.1007/s11010-013-1665-z Ko, 1998, The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan, Atherosclerosis, 141, 259, 10.1016/S0021-9150(98)00179-8 Ombres, 1998, The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients, Arterioscler Thromb Vasc Biol, 18, 1611, 10.1161/01.ATV.18.10.1611 Turban, 2001, A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin, Atherosclerosis, 154, 633, 10.1016/S0021-9150(00)00495-0 Haymond, 2003, Measuring insulin resistance: a task worth doing. But how?, Pediatr Diabetes, 4, 115, 10.1034/j.1399-5448.2003.00024.x Meigs, 2007, Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome, Diabetes Care, 30, 1219, 10.2337/dc06-2484 Strazzullo, 2008, Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population, Metabolism, 57, 355, 10.1016/j.metabol.2007.10.010 WHO Consultation, 1999 Ferrannini, 1997, European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity, J Clin Invest, 100, 1166, 10.1172/JCI119628 Mejía-Benítez, 2013, Analysis of the contribution of FTO, NPC1, ENPP1, NEGR1, GNPDA2 and MC4R genes to obesity in Mexican children, BMC Med Genet, 14, 21, 10.1186/1471-2350-14-21 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Aradillas-García, 2012, Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents, Eur J Endocrinol, 166, 301, 10.1530/EJE-11-0844 WHO, 2006 Cole, 2000, Establishing a standard definition for child overweight and obesity worldwide: international survey, Br Med J, 320, 1240, 10.1136/bmj.320.7244.1240 Wallace, 1979, Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA: the effect of single base pair mismatch, Nucleic Acids Res, 6, 3543, 10.1093/nar/6.11.3543 López-Flores, 2009, Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides, Toxicol Lett, 188, 84, 10.1016/j.toxlet.2009.03.010 Pérez-Herrera, 2008, PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico, Toxicol Appl Pharmacol, 230, 261, 10.1016/j.taap.2008.02.021 Huen, 2013, Associations of PON1 and genetic ancestry with obesity in early childhood, PLoS One, 8, e62565, 10.1371/journal.pone.0062565 Hernández, 2003, Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure, Hum Exp Toxicol, 22, 565, 10.1191/0960327103ht400oa Gutiérrez, 2012, 129 Andersen, 2012, Paraoxonase 1 polymorphism and prenatal pesticide exposure associated with adverse cardiovascular risk profiles at school age, PLoS One, 7, e36830, 10.1371/journal.pone.0036830 Dell'Omo, 2014, Q192R Paraoxonase (PON)1 polymorphism, insulin sensitivity, and endothelial function in essential hypertensive men, Clin Med Insights Cardiol, 8, 57, 10.4137/CMC.S15493 Wallace, 2002, Review The assessment of insulin resistance in man, Diabet Med, 7, 527, 10.1046/j.1464-5491.2002.00745.x Yin, 2013, Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers, Diabetol Metab Syndr, 5, 71, 10.1186/1758-5996-5-71 Holst-Schumacher, 2009, Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren, Food Nutr Bull, 2, 161, 10.1177/156482650903000208 López-Capapé, 2006, Frequency of the metabolic syndrome in obese Spanish pediatric population, Eur J Endocrinol, 155, 313, 10.1530/eje.1.02206 Rojas-García, 2005, Genetic polymorphisms and activity of PON1 in a Mexican population, Toxicol Appl Pharmacol, 205, 282, 10.1016/j.taap.2004.10.015